Clinical Trials in Colorado

Showing 5881-5900 of 18,143 trials

HIFEM and Radiofrequency for Muscular System Function Improvement

NCT06703749

The goal of this clinical trial is to investigate the effect of the BTL-899M device on muscular system function in adult subjects seeking treatment for improving their muscular system function in the lower extremities. The main question it aims to answer is: Whether the BTL-899M device is effective for muscular system function improvement 3 months posttreatment compared to the sham group, based on the dynamometer measurement. Researchers will compare a sham group to see if the device is effective. Participants will complete four treatment visits and two follow-up visits. Their strength will be recorded via a dynamometer.

Muscle DamageMuscle StrengthMuscle Weakness

BTL Industries Ltd.33 participantsStarted Apr 2024

Scottsdale, Arizona, United States • Greenwood Village, Colorado, United States • Palm Beach Gardens, Florida, United States

COMPLETEDPhase 244 miles

A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer

NCT02675231

The purpose of this study is to evaluate the effectiveness of abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus physicians choice standard of care chemotherapy in women with hormone receptor positive (HR+), human epidermal growth factor receptor 2 positive (HER2+) locally advanced or metastatic breast cancer after prior exposure to at least two HER2-directed therapies for advanced disease.

Hormone Receptor Positive Breast CancerHER-2 Positive Breast Cancer

Eli Lilly and Company237 participantsStarted May 2016

Bakersfield, California, United States • Fullerton, California, United States • Los Angeles, California, United States +90 more locations

HIFEM and Radiofrequency for Muscular System Function Improvement

A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer

Find Trials by Condition in Colorado

A Study to Determine the Recommended Dose and Regimen and to Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM)

INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)

A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)

A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes

Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity

Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery

A Study of ZN-c3 in Patients With Ovarian Cancer

Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction

A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE)

Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

LEGION Hinge Safety and Efficacy Study

A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)

A Study of SPY002-072 in Healthy Volunteers

MIRACLE of LIFE Study

RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)

Evoked Responses as Pharmacodynamic Biomarkers in Healthy and Schizophrenic Participants (MK-4334-007)